Tirzepatide acts on two receptors at once, GIP and GLP-1. Both are receptors for hormones the gut releases around meals, and both play a part in appetite and in how the body handles blood sugar. For people in the Twin Cities, it is the medication behind Bodi Envi's Personalized Compounded Tirzepatide Weight-Management Programs.
Personalized Compounded Tirzepatide is a version of that active ingredient prepared by a licensed compounding pharmacy from a prescription written for an individual patient. It is taken as a weekly injection, and the starting dose and any later change are decided by the prescribing provider, not by the patient and not by Bodi Envi.
Compounded medications sit outside FDA approval. Personalized Compounded Tirzepatide is not FDA-approved, is not equivalent to Mounjaro® and Zepbound®, and is not reviewed by the FDA for safety, effectiveness or quality before it is marketed. That is why each prescription rests on a licensed provider's individual judgement. Brand names are trademarks of their respective owners. Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.